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1. Introduction 
Acetyl~ho~nesterase (a~etylcho~ne hydrolase, 
EC 3.1.1.7) is the enzyme thought to be responsible 
for the termination of the action of the neurotrans- 
mitter acetylcholine, at the cholinergic synapses [ 11. 
Nevertheless, its presence is not limited to the 
cholinergic postsynaptic membrane, being widely 
distributed in nerve and muscle cell membranes, 
electrogenic tissue from electric fish, and erythrocyte 
membranes. This circumstance suggests the possibility 
that acetylcholinesterase may be involved in other 
membrane functions as well [ 1,2] and explains the 
difficulties observed when trying to use the enzyme 
as a marker for the presence of cholinergic synapses 
[3,4]. The identification of several structural forms 
of the enzyme, characterized by definite sedimenta- 
tion coefficients [S-13], has opened the way for the 
assignment of different molecular forms to different 
localizations and/or potential functions [7,9,10,12]. 
Special attention has been paid to the so-called asym- 
metric or tailed forms of the enzyme composed of 
l-3 tetramers of the catalytic subunit (mol. wt 
280 000) associated to a filamentous, collagen-like 
tail, probably implicated in the anchorage of the 
enzyme to the cell membrane matrix 112-l 51. The 
specific association of a 16 S form of acetylchol~es- 
terase to the muscle junctional membrane (the post- 
synaptic element of the neuromuscular cholinergic 
synapse) was detected [7]. Other fast-sedimenting 
forms of the enzyme, associated to cholinergic 
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synapses, have been described in chick [9], mouse 
1161, and human [12J muscle, and in chick 191, rat 
[ lo,11 ] and bovine [ 131 ganglia. Furthermore, a 
direct dependence of the initial synthesis (induction) 
and/or maintenance of said molecular forms of 
acetylcholinesterase upon the integrity of the pre- 
synaptic component has been demonstrated in several 
cases [9,17-191. However,it hasnot yet been possible 
to find a likely candidate for the synaptic form of the 
enzyme in the central nervous system [8,9,20]. 
It has been suggested [12,13] that the molecular 
and structural patterns of association of the acetyl- 
cholinesterase catalytic subunits (and tail proteins) 
may be very much .the same for different species and 
tissues. This paper describes the release by collagenase 
of two molecular species of acetylcholinesterase of 
21 .S S and 16.5 S, from the young chick visual sys- 
tem (both retina and optic tectum). It is postulated 
that these two collagenase-released enzyme forms 
derive from tailed native a~etyl~holinesterase pecies 
containing 3 and 2 tetrameric clusters of catalytic 
subunits, respectively (forms A,* and As of [ 12,I 3 J). 
2. Experimental 
2.1. Gtyerat procedure 
White-Leghorn, Shaver strain chicks, lo-20 days, 
were used in this study. They were kept on a 12 h 
light/12 h dark schedule. The retinas and optic lobes 
were dissected over ice, and homogenized in 10 vol. 
10 mM Tris-HCl (pH 7), 1% Triton X-l 00,l M NaCl, 
and 50 mM MgClz (henceforth referred to as Tris- 
Triton-salt buffer, or homogenization buffer), at 
4’C, in a glass-glass conical homogenizer (Kontes 
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Duall) [ 171. This homogenate was centrifuged at 
110 000 X g, for 30 min, at 2°C (Sorvall OTD-2 
ultracentrifuge). The supernatant was set aside, and 
the pellet was rehomogenized as before, and cen- 
trifuged again. This second pellet, representing the 
material insoluble in homogenization buffer, was 
further digested with collagenase or pronase, as 
described below. The digest was, once again, cen- 
trifuged at 110 000 X g, and the supernatant was 
analyzed by sedimentation in linear sucrose gradients. 
2.2. Collagenase and pronase treatments 
For collagenase digestion, the material was resus- 
pended in a buffer containing 10 mM Tris-HCl 
(pH 7) 0.1 NaCl, 50 mM MgClz, 5 mM CaCl,, and 
collagenase (EC 3.4.24.3) at 100 units/ml (Sigma 
type VI, devoid of protease activity, 840 units/mg). 
Routinely, the incubation was performed at 37”C, for 
30 min, in a shaking water bath. Digestion with 
pronase (final cont. 0.25 mg/ml) was carried out in 
50 mM potassium phosphate buffer (pH 7) under the 
same conditions. 
2.3. Sedimentation analysis 
The proteins solubilized by the Tris-Triton-salt 
buffer, or by means of collagenase or pronase diges- 
tion, were analyzed by sedimentation through a 
5--20% sucrose gradient, prepared in this Tris-Triton- 
salt homogenization buffer. The sedimentation coeffi- 
cients were estimated according to [21], using 
Escherichia coli &galactosidase (EC 3.2.1.23; 16 S), 
beef liver catalase (EC 1 .l 1 .1.6; 11.3 S) and E. coZi 
alkaline phosphatase (EC 3.1.3.1; 6.1 S) as internal 
marker enzymes. The centrifugation was carried out 
in a SW40Ti (Beckman) rotor, at 154 000 X g, 4”C, 
for 18-20 h. Fractions (-0.4 ml) were collected and 
assayed for acetylcholinesterase and marker enzymes. 
2.4. Enzymatic assays 
Acetylcholinesterase was analyzed as in [22], using 
acetylthiocholine iodide as the substrate, 0.06 mM 
tetraisopropylpyrophosphoramide (Sigma) as a buty- 
rylcholinesterase inhibitor (EC 3.1 .1.8) and 0.01 mM 
1,5-bis(4-allyldimethylammoniumphenyl)pentan-3- 
one dibromide (BW 284C5 1, Wellcome Lab., Becken- 
ham) as an acetylcholinesterase inhibitor. For more 
precise, comparative measurements of some fractions, 
a radiometric method of assay [3] was employed, after 
localization of the peaks according to- [22]. As for the 
marker enzymes, the procedures recommended in the 
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technical bulletins accompanying the products (Sigma 
Chem. Co., St Louis) were followed in all experi- 
ments. 
3. Results 
When day 10 chick retinal or tectal tissues are 
extracted with the typical Tris-Triton-salt buffer, 
and the extract is analyzed by sedimentation in 
sucrose gradients, two peaks of acetylcholinesterase 
activity, with sedimentation coefficients of 11 S 
(retina, 11.02 + 0.40; tectum, 10.84 f 0.34) and 6 S 
(retina, 6.15 f 0.18; tectum, 6.20 + 0.34) can be 
observed (fig.1). This agrees closely with the results 
obtained by other authors working on chick brain 
[9,201. 
In our experience, this buffer extract, in the case 
of the lo-day old chick, accounts for -95% (retina) 
or 94% (tectum) of the total enzyme activity in the 
initial homogenate. To investigate the nature of the 
5-6% not extracted by the Tris-Triton-salt buffer 
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Fig.1. Sedimentation pattern of the molecular species of 
acetylcholinesterase olubilized, from 10 day chick retina, by 
means of a Tris-Triton-salt buffer. Sedimentation direction 
is to the left. The enzyme activity is given in arbitrary units, 
Rroportional to the AA,,, [22]. The arrows point to the 
position of the markers in the gradient: g, fl-galactosidase 
(16 S); c, catalase (11.3 S); p, alkaline phosphatase (6.1 S). 
10 day chick tectum gives the same qualitative result. 
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Fig.2. Sedimentation patterns of the molecular species of 
acetylcholinesterase r leased by collagenase from the Tris- 
Triton-salt-insoluble residue in 10 day chick retina (left), 
and optic tectum (right). Experimental details as in fig.1. 
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Fig.3. Specificity of the collagenase action. The residual 
pellet after extraction of 20 day chick tecta with Tris- 
Triton-salt buffer was divided into 3 parts: digested with 
collagenase (o-0); digested with pronase (o---o); and 
simply incubated at 37°C for the same time (o----o). After 
these treatments, the 3 samples were centrifuged at high 
speed, and the supernatants analyzed by sucrose gradient 
centrifugation. The 3 independent sedimentation runs have 
been matched to identical marker positions. Other details as 
in fig.1. 
we subjected the residual pellet to digestion with 
highly purified, protease-free collagenase. This treat- 
ment released SO-70% of the remaining activity in 
that pellet. The sedimentation pattern of the mole- 
cular forms of acetylcholinesterase released by 
collagenase can be seen in fig.2. As the figure shows, 
two new peaks with acetylcholinesterase activity 
are now visible, both in retina and tectum. The 
apparent sedimentation coefficients for these two 
new forms of the enzyme are 21.5 S (retina, 
2 1.80 f 0.7 1; tectum, 2 1.55 + 0.36) and 16.5 S 
(retina, 16.70 f 0.14; tectum, 16.54 f 0.30). In terms 
of activity they represent, in the case of the retina, 
a 0.66% (21.5 S), and 0.88% (16.5 S) of the total 
homogenate activity; as for the optic tectum, they 
constitute the 0.19% (21.5 S) and 0.25% (16.5 S) of 
the initial homogenate activity. Studies with specific 
inhibitors have shown that these peaks are 285% 
true acetylcholinesterase. That the release of these 
two new molecular forms of acetylcholinesterase is 
due to the specific action of collagenase and not to 
the increased temperature during the digestion (37”C, 
in contrast with the 4’C maintained during the extrac- 
tion with the Tris-Triton-salt buffer), is demonstrated 
in the control experiment illustrated in fig.3. We see 
that only collagenase, and not the higher temperature, 
or even pronase, can release the 21.5 S and 16.5 S 
forms of acetylcholinesterase from the Tris-Triton- 
salt-insoluble residue from chick tectum. 
Next, we did some experiments to ascertain the 
individuality of, or the possible mutual relationship 
between, the 21.5 S and 16.5 S forms of acetylcholi- 
nesterase. First we varied the parameters relative to 
the collagenase digestion, namely incubation time 
and collagenase concentration. No qualitative or 
quantitative changes in the amount and relative 
proportion of the 21.5 S and 16.5 S forms were 
observed with digestions of 15-60 min, and 50-200 
units collagenase/ml. To confirm the individuality of 
the two new molecular forms of acetylcholinesterase 
we took the fractions belonging to the 21.5 S and 
16.5 S peaks in the retina gradient in fig.2, dialyzed 
them against homogenization buffer, and digested 
them again with collagenase (incubating a portion of 
the material at 37”C, without collagenase, as a control 
for the stability of the enzyme). The sedimentation 
patterns given in fig.4 show that collagenase just 
releases the 21.5 S and 16.5 S acetylcholinesterases 
from the Tris-Triton-salt-insoluble pellet, without 
further modifying them. On the other hand, pronase 
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Fig.4. Stability of the 21.5 S and 16.5 S acetylcholinesterase 
molecules to further action of collagenase. The 21.5 S and 
16.5 S peaks from 10 day chick retina (fig.2, left panel) 
were isolated and divided each into 3 parts: redigested with 
collagenase; redigested with pronase; and the control, was 
just incubated at 37°C for the duration of the enzymatic 
digestion. The ordinate scale in the pronase-treated peaks has 
been reduced for the sake of clarity, since in the pronase gra- 
dient only 35% of the activity (versus 100% in the collagenase 
and control gradients) was recovered. Other details as in fig.1. 
(0.25 mg/ml), under the same incubation conditions, 
converts most of the 21.5 S and 16.5 S forms to the 
known 11 S and 6 S (and 4 S) species. While the 
treatment with collagenase did not affect the activity 
of the enzyme, after the pronase digestion only 
-35% of the initial activity was recovered. 
4. Discussion 
We have described how collagenase can release two 
molecular species of acetylcholinesterase 21.5 S and 
16.5 S, from the material insoluble after homogenizing 
chick retina and optic tectum in a Tris-Triton-salt 
buffer. These two forms seem to originate from inde- 
pendent tailed native forms, and are not affected by 
subsequent reatment with collagenase. However, 
limited exposure to pronase converts them, to a great 
extent, to the more common 11 S, 6 S and 4 S forms. 
In [23], the stepwise modification by collagenase of 
the tailed acetylcholinesterase forms of Electrophoms 
has been analyzed at 2O’C and 37°C. While we have 
not been able to confirm, in the case of the chick 
enzyme, the final conversion by collagenase of the 
tailed enzyme forms to the 11 S species, at least under 
our experimental conditions, the apparently increased 
release of the 11 S form, upon incubation of the 
Tris-Triton-salt insoluble pellet at 37°C in the 
presence of collagenase (fig.3) suggests that the action 
of collagenase on the membrane-bound enzyme may 
be somewhat more complex than just releasing the 
2 1.5 S and 16.5 S acetylcholinesterase forms. 
For day lo-old chicks, the retinal fast-sedimenting 
forms account, together, for -1.5% of the total 
activity in the initial retinal homogenate; in the case 
of tectum, this proportion is -0.5%. This fact, and 
the potential difficulty in extracting them in their 
native form have, most likely, prevented their 
identification [9,20]. Nevertheless, using our proce- 
dure it is possible to detect them as early as day 8 of 
embryonic development (unpublished results). 
What may be actually important about these two 
collagenase-released forms is that they bear out the 
existence, in the central nervous system, or multite- 
trameric tailed species of acetylcholinesterase, as with 
all other excitable tissues studied in depth. It is well 
known that collagenase, both in the electric fish 
enzyme forms, and in muscle, cleaves specifically the 
collagen-like tail without disorganizing the assembly 
of catalytic subunits (tetramers). This process results 
in a shift of the coefficient of sedimentation towards 
higher values since, in spite of the loss of protein 
mass, the increased symmetry of the tailless enzyme 
causes it to sediment faster than its native counterpart 
[13-16,23-251. Within this structural model, our 
21.5 S form could derive from the brain equivalent of 
the 19.5 S native form (Alz) found [9] in the chick 
muscle and ciliary ganglion, and thought to be directly 
involved in cholinergic neurotransmission (we have 
observed two acetylcholinesterase species in embryonic 
chick muscle, extractable by the standard homogeni- 
zation buffer, with sedimentation coefficients of 
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19.6 S and 15 S, giving rise to 21.5 S and 16.5 S 
forms upon collagenase treatment). In agreement with 
the general model [ 131, the 16.5 S and 21.5 S species 
would then correspond to the assemblies of 2 and 3 
tetramers of catalytic subunits including, at least, the 
portion of the tail that keeps the tetramers together 
[ 15,231. To confirm this working hypothesis it is, 
nevertheless, necessary to isolate and characterize the 
fully-tailed native enzyme molecular species. The fact 
that they are not releasable by the standard Tris- 
Triton-salt buffer suggests that they may interact 
with neuronal membranes in some different way from 
those proposed so far, namely hydrophobic interact- 
ions with specific lipid domains in the membrane 
[ 13 ,15,26] and/or ionic interactions with basal 
lamina-like structures [ 13,271. We are working on 
these problems in the hope that all new developments 
on the structure and molecular properties of an 
enzyme so abundant and ubiquitous in the nervous 
system will be of decisive help, not only in under- 
standing more deeply the mechanism of cholinergic 
neurotransmission, but also in gaining new insights on 
other possible roles of acetylcholinesterase in 
excitable membranes. 
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